Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 3
2013 1
2014 2
2015 3
2016 3
2017 1
2018 6
2019 4
2020 11
2021 2
2022 1
2023 4
2024 10

Text availability

Article attribute

Article type

Publication date

Search Results

48 results

Results by year

Filters applied: . Clear all
Page 1
Environment and systemic lupus erythematosus.
Cardelli C, Zucchi D, Elefante E, Signorini V, Menchini M, Stagnaro C, Mosca M, Tani C. Cardelli C, et al. Among authors: stagnaro c. Clin Exp Rheumatol. 2024 May;42(5):1104-1114. doi: 10.55563/clinexprheumatol/17vmqc. Epub 2024 May 14. Clin Exp Rheumatol. 2024. PMID: 38743446 Free article. Review.
Riociguat in patients with early diffuse cutaneous systemic sclerosis (RISE-SSc): open-label, long-term extension of a phase 2b, randomised, placebo-controlled trial.
Distler O, Allanore Y, Denton CP, Kuwana M, Matucci-Cerinic M, Pope JE, Atsumi T, Bečvář R, Czirják L, Hachulla E, Ishii T, Ishikawa O, Johnson SR, De Langhe E, Stagnaro C, Riccieri V, Schiopu E, Silver RM, Smith V, Steen V, Stevens W, Szücs G, Truchetet ME, Wosnitza M, Laapas K, Kramer F, Khanna D. Distler O, et al. Among authors: stagnaro c. Lancet Rheumatol. 2023 Nov;5(11):e660-e669. doi: 10.1016/S2665-9913(23)00238-2. Lancet Rheumatol. 2023. PMID: 38251533 Clinical Trial.
Riociguat in patients with early diffuse cutaneous systemic sclerosis (RISE-SSc): randomised, double-blind, placebo-controlled multicentre trial.
Khanna D, Allanore Y, Denton CP, Kuwana M, Matucci-Cerinic M, Pope JE, Atsumi T, Bečvář R, Czirják L, Hachulla E, Ishii T, Ishikawa O, Johnson SR, De Langhe E, Stagnaro C, Riccieri V, Schiopu E, Silver RM, Smith V, Steen V, Stevens W, Szücs G, Truchetet ME, Wosnitza M, Laapas K, de Oliveira Pena J, Yao Z, Kramer F, Distler O. Khanna D, et al. Among authors: stagnaro c. Ann Rheum Dis. 2020 May;79(5):618-625. doi: 10.1136/annrheumdis-2019-216823. Ann Rheum Dis. 2020. PMID: 32299845 Free PMC article. Clinical Trial.
One year in review 2016: systemic sclerosis.
Barsotti S, Stagnaro C, d'Ascanio A, Della Rossa A. Barsotti S, et al. Among authors: stagnaro c. Clin Exp Rheumatol. 2016 Sep-Oct;34 Suppl 100(5):3-13. Epub 2016 Jul 18. Clin Exp Rheumatol. 2016. PMID: 27463613 Free article. Review.
Imaging of joints in systemic lupus erythematosus.
Tani C, Carli L, Stagnaro C, Elefante E, Signorini V, Balestri F, Delle Sedie A, Mosca M. Tani C, et al. Among authors: stagnaro c. Clin Exp Rheumatol. 2018 Sep-Oct;36 Suppl 114(5):68-73. Epub 2018 Oct 1. Clin Exp Rheumatol. 2018. PMID: 30296972 Free article. Review.
Biomarker analysis from the phase 2b randomized placebo-controlled trial of riociguat in early diffuse cutaneous systemic sclerosis.
Khanna D, Kramer F, Höfler J, Ghadessi M, Sandner P, Allanore Y, Denton CP, Kuwana M, Matucci-Cerinic M, Pope JE, Atsumi T, Bečvář R, Czirják L, De Langhe E, Hachulla E, Ishii T, Ishikawa O, Johnson SR, Riccieri V, Schiopu E, Silver RM, Smith V, Stagnaro C, Steen V, Stevens W, Szücs G, Truchetet ME, Wosnitza M, Distler O. Khanna D, et al. Among authors: stagnaro c. Rheumatology (Oxford). 2024 Mar 9:keae150. doi: 10.1093/rheumatology/keae150. Online ahead of print. Rheumatology (Oxford). 2024. PMID: 38460548
Treatment With Anifrolumab for Discoid Lupus Erythematosus.
Trentin F, Tani C, Elefante E, Stagnaro C, Zucchi D, Mosca M. Trentin F, et al. Among authors: stagnaro c. JAMA Dermatol. 2023 Feb 1;159(2):224-226. doi: 10.1001/jamadermatol.2022.5242. JAMA Dermatol. 2023. PMID: 36427219
Symmetric peripheral polyarthritis developed during SARS-CoV-2 infection.
Talarico R, Stagnaro C, Ferro F, Carli L, Mosca M. Talarico R, et al. Among authors: stagnaro c. Lancet Rheumatol. 2020 Sep;2(9):e518-e519. doi: 10.1016/S2665-9913(20)30216-2. Epub 2020 Jul 13. Lancet Rheumatol. 2020. PMID: 32838313 Free PMC article. No abstract available.
48 results